Safety [hcpp]
Treatments [topp]
Prolactinomas [neop]
Introduction [hlca]
Prolactinomas [neop]
hormone secreting [horm]
Pituitary Tumors [neop]
Accounting [ocac]
Approximately [qlco]
Pituitary Tumors [neop]
Infertility [dsyn]
Gonadal [bpoc]
sexual dysfunction [dsyn]
Relevant [qlco]
Sex [orgf]
Area [geoa]
Covered [ftcn]
Focus [spco]
Safety [hcpp]
TOLERABILITY [resa]
Therapeutic [topp]
Approaches [spco]
Prolactinomas [neop]
Complications [patf]
TRANS [idcn]
Sphenoidal [spco]
Surgery [bmod]
depend [medd]
Tumor size [spco]
Mortality rate [qnco]
Patients [podg]
Microprolactinomas [neop]
Patients [podg]
Receive [qlco]
Pituitary, NOS [bpoc]
radiotherapy [inpr]
hormone deficiency [dsyn]
Following [tmco]
Decade [qnco]
Cerebrovascular accidents [dsyn]
Second [qnco]
Brain Tumors [neop]
Optic Neuropathy [dsyn]
Rarely [qlco]
treatment [ftcn]
Prolactinomas [neop]
Based [ftcn]
Dopamine Agonists [phsu]
cabergoline [orch, phsu]
Increased [qnco]
Relevant [qlco]
cardiac valvulopathy [dsyn]
Patients [podg]
Prolactinomas [neop]
With [qlco]
Parkinson Disease [dsyn]
Pd [elii]
debate [acty]
Increased [qnco]
Valvulopathy [dsyn]
Prolactinomas [neop]
Correlation [qlco]
Abnormalities [cgab]
cabergoline [orch, phsu]
Duration [tmco]
Cumulative Dose [cnce]
Expert Opinion [cnce]
Dopamine Agonists [phsu]
Well [qlco]
Main [qlco]
Safety [hcpp]
Concerns [idcn]
Relevant [qlco]
Valvulopathy [dsyn]
Following [tmco]
treatment [ftcn]
cabergoline [orch, phsu]
Rarely [qlco]
Patients [podg]
Prolactinomas [neop]
